Imricor Total Current Liabilities vs Current Deferred Revenue Analysis

IMR Stock   1.16  0.06  5.45%   
Imricor Medical financial indicator trend analysis is infinitely more than just investigating Imricor Medical Systems recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Imricor Medical Systems is a good investment. Please check the relationship between Imricor Medical Total Current Liabilities and its Current Deferred Revenue accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Imricor Medical Systems. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Total Current Liabilities vs Current Deferred Revenue

Total Current Liabilities vs Current Deferred Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Imricor Medical Systems Total Current Liabilities account and Current Deferred Revenue. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Imricor Medical's Total Current Liabilities and Current Deferred Revenue is 0.57. Overlapping area represents the amount of variation of Total Current Liabilities that can explain the historical movement of Current Deferred Revenue in the same time period over historical financial statements of Imricor Medical Systems, assuming nothing else is changed. The correlation between historical values of Imricor Medical's Total Current Liabilities and Current Deferred Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Current Liabilities of Imricor Medical Systems are associated (or correlated) with its Current Deferred Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Current Deferred Revenue has no effect on the direction of Total Current Liabilities i.e., Imricor Medical's Total Current Liabilities and Current Deferred Revenue go up and down completely randomly.

Correlation Coefficient

0.57
Relationship DirectionPositive 
Relationship StrengthWeak

Total Current Liabilities

Total Current Liabilities is an item on Imricor Medical balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Imricor Medical Systems are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Current Deferred Revenue

Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.
Most indicators from Imricor Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Imricor Medical Systems current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Imricor Medical Systems. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Issuance Of Capital Stock is likely to gain to about 10.1 M in 2024, whereas Selling General Administrative is likely to drop slightly above 3.9 M in 2024.
 2021 2022 2023 2024 (projected)
Depreciation And Amortization918.1K1.0M707.5K525.5K
Interest Income16.7K108.0K63.0K59.9K

Imricor Medical fundamental ratios Correlations

0.110.110.330.83-0.770.890.760.78-0.72-0.330.260.890.710.440.10.190.890.450.0-0.240.670.320.29-0.20.96
0.110.770.71-0.3-0.48-0.040.450.130.44-0.740.71-0.190.510.77-0.710.88-0.190.470.580.660.330.560.570.62-0.06
0.110.770.95-0.44-0.470.230.50.310.55-0.90.98-0.270.550.8-0.950.53-0.270.58-0.040.910.470.640.690.91-0.08
0.330.710.95-0.23-0.640.460.690.570.39-0.980.99-0.080.710.79-0.890.47-0.080.77-0.140.80.690.790.830.820.14
0.83-0.3-0.44-0.23-0.480.670.450.49-0.960.2-0.290.960.40.010.63-0.060.960.080.07-0.740.36-0.09-0.15-0.70.91
-0.77-0.48-0.47-0.64-0.48-0.74-0.96-0.670.250.7-0.6-0.48-0.96-0.770.27-0.42-0.48-0.72-0.1-0.09-0.85-0.67-0.6-0.12-0.64
0.89-0.040.230.460.67-0.740.80.87-0.57-0.450.40.750.740.39-0.07-0.020.750.59-0.41-0.080.80.430.41-0.010.86
0.760.450.50.690.45-0.960.80.75-0.24-0.750.630.490.990.72-0.340.440.490.82-0.010.150.950.710.640.190.66
0.780.130.310.570.49-0.670.870.75-0.35-0.60.470.580.680.29-0.250.110.580.78-0.340.090.850.660.70.180.73
-0.720.440.550.39-0.960.25-0.57-0.24-0.35-0.390.43-0.94-0.190.13-0.720.14-0.940.13-0.030.79-0.160.330.350.76-0.85
-0.33-0.74-0.9-0.980.20.7-0.45-0.75-0.6-0.39-0.940.08-0.76-0.760.86-0.520.08-0.860.07-0.74-0.77-0.89-0.9-0.77-0.14
0.260.710.980.99-0.29-0.60.40.630.470.43-0.94-0.130.670.83-0.90.48-0.130.67-0.120.820.610.70.760.840.07
0.89-0.19-0.27-0.080.96-0.480.750.490.58-0.940.08-0.130.440.120.460.061.00.130.04-0.570.41-0.07-0.09-0.530.97
0.710.510.550.710.4-0.960.740.990.68-0.19-0.760.670.440.78-0.370.510.440.80.060.20.910.680.620.220.61
0.440.770.80.790.01-0.770.390.720.290.13-0.760.830.120.78-0.60.650.120.470.270.510.530.480.460.490.27
0.1-0.71-0.95-0.890.630.27-0.07-0.34-0.25-0.720.86-0.90.46-0.37-0.6-0.450.46-0.580.12-0.98-0.39-0.66-0.72-0.980.28
0.190.880.530.47-0.06-0.42-0.020.440.110.14-0.520.480.060.510.65-0.450.060.360.730.390.30.320.340.340.13
0.89-0.19-0.27-0.080.96-0.480.750.490.58-0.940.08-0.131.00.440.120.460.060.130.04-0.570.41-0.07-0.09-0.530.97
0.450.470.580.770.08-0.720.590.820.780.13-0.860.670.130.80.47-0.580.360.13-0.190.420.930.940.910.480.34
0.00.58-0.04-0.140.07-0.1-0.41-0.01-0.34-0.030.07-0.120.040.060.270.120.730.04-0.19-0.11-0.22-0.13-0.17-0.19-0.02
-0.240.660.910.8-0.74-0.09-0.080.150.090.79-0.740.82-0.570.20.51-0.980.39-0.570.42-0.110.20.520.590.99-0.41
0.670.330.470.690.36-0.850.80.950.85-0.16-0.770.610.410.910.53-0.390.30.410.93-0.220.20.810.760.260.59
0.320.560.640.79-0.09-0.670.430.710.660.33-0.890.7-0.070.680.48-0.660.32-0.070.94-0.130.520.810.940.570.15
0.290.570.690.83-0.15-0.60.410.640.70.35-0.90.76-0.090.620.46-0.720.34-0.090.91-0.170.590.760.940.640.12
-0.20.620.910.82-0.7-0.12-0.010.190.180.76-0.770.84-0.530.220.49-0.980.34-0.530.48-0.190.990.260.570.64-0.36
0.96-0.06-0.080.140.91-0.640.860.660.73-0.85-0.140.070.970.610.270.280.130.970.34-0.02-0.410.590.150.12-0.36
Click cells to compare fundamentals

Imricor Medical Account Relationship Matchups

Imricor Medical fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets10.5M33.6M26.9M13.7M8.3M15.9M
Short Long Term Debt Total1.3M1.4M1.7M4.5M10.4M10.9M
Other Current Liab388.6K503.2K175.3K23.4K3.9M4.1M
Total Current Liabilities1.4M2.3M2.7M2.1M6.7M7.0M
Total Stockholder Equity7.0M28.8M22.4M7.5M(12.8M)(12.2M)
Other Liab592.9K617.2K509.6K536.9K483.2K459.0K
Net Tangible Assets7.0M28.8M22.4M7.5M8.6M8.3M
Property Plant And Equipment Net2.7M3.9M3.6M3.6M4.6M2.9M
Net Debt(4.9M)(23.8M)(16.8M)(1.2M)9.6M10.1M
Retained Earnings(40.4M)(52.9M)(72.6M)(90.0M)(165.0M)(156.7M)
Accounts Payable541.0K529.1K686.7K259.3K2.1M2.2M
Cash5.0M25.1M18.5M5.7M831.5K789.9K
Non Current Assets Total3.7M4.6M4.2M4.0M6.4M3.7M
Non Currrent Assets Other969.2K754.7K288.0K119.1K1.5M1.6M
Other Assets1.0M969.2K754.7K565.2K(3.9M)(3.7M)
Long Term Debt2.3M9.6M0.02.2M8.6M4.5M
Cash And Short Term Investments5.0M25.1M18.5M5.7M831.5K789.9K
Long Term Debt Total1.1M668.3K226.7K2.2M2.0M2.0M
Liabilities And Stockholders Equity10.5M33.6M26.9M13.7M8.3M15.9M
Non Current Liabilities Total2.1M2.5M1.7M4.1M18.3M19.2M
Capital Surpluse47.4M81.7M95.0M97.5M112.1M59.6M
Inventory1.2M3.1M2.6M2.3M1.7M1.6M
Other Current Assets287.8K491.6K1.5M3.2M2.6M2.7M
Total Liab3.5M4.8M4.5M6.2M17.1M17.9M
Total Current Assets6.8M28.9M22.7M9.7M5.8M5.5M
Short Term Debt127.3K198.0K518.7K867.2K667.9K376.4K
Common Stock47.5M81.7M95.0M97.5M24.8K23.5K
Property Plant Equipment2.7M3.9M3.6M3.6M4.1M2.6M
Net Receivables256.3K223.2K94.7K125.5K392.6K412.2K
Capital Lease Obligations694.0K1.8M1.7M2.3M1.4M1.4M
Net Invested Capital10.0M37.4M22.4M9.7M227.9K216.5K
Property Plant And Equipment Gross3.9M5.3M5.5M6.1M6.4M5.5M
Capital Stock47.5M81.7M95.0M97.5M103.8M86.7M
Net Working Capital7.7M34.6M20.0M7.6M(628.2K)(596.8K)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Imricor Stock Analysis

When running Imricor Medical's price analysis, check to measure Imricor Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Imricor Medical is operating at the current time. Most of Imricor Medical's value examination focuses on studying past and present price action to predict the probability of Imricor Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Imricor Medical's price. Additionally, you may evaluate how the addition of Imricor Medical to your portfolios can decrease your overall portfolio volatility.